Meeting
2012 Genitourinary Cancers Symposium
Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.
Authors
Elizabeth J. Hovey
Prince of Wales Hospital, Sydney, Australia
Elizabeth J. Hovey , Paul L. De Souza , Gavin M. Marx , Phillip Parente , Tal Rapke , Andrew Hill , Antonino Bonaventura , Antonio Michele , Paul Stanley Craft , Ehtesham A. Abdi , Andrew R. Lloyd
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Clinical Trial Registration Number
NCT00917748
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 211)
DOI
10.1200/jco.2012.30.5_suppl.211
Abstract #
211
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Phase 3 randomized controlled trial comparing the effectiveness of dexamethasone in reducing cancer-associated fatigue in patients on palliative chemotherapy.
First Author: Venkatraman Radhakrishnan
Poster
2023 ASCO Annual Meeting
Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI).
First Author: Michelle Christine Janelsins
Poster
2019 ASCO Annual Meeting
Personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel chemotherapy: A randomized, double-blind, placebo-controlled, phase III trial.
First Author: Masanori Noguchi
First Author: Maha Hussain